In both GBM and LGG, we also separately analyzed the genetically characterized subgroups with IDH mutation, with IDH mutation and 1p/19q codeletion, with wild type (wt) IDH, and with methylated or unmethylated MGMT promoter. The gene discussed is IDH1; the disease is glioblastoma.